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Abstract: Human resistance to infection by schistosomes is associated to a strong Th2 immune. However a persistent Th2 
response can cause severe kidney and liver disease in human. In this review, we mainly focused on the control of infection 
levels caused by schistosomes. Several experimental models allowed us to better understand the immunological mecha-
nisms of the host against schistosome infection. High IgE and eosinophil levels are associated with resistance to infection 
by schistosomes and this effect is counterbalanced by IgG4. IgE and eosinophils are highly dependent on IL-4, IL-13, and 
Il-5, which are three main Th2 cytokines. We also examined the genetic factors involved in human susceptibility to infec-
tion by schistosomiasis. Infection levels are mainly regulated by a major locus SM1, in 5q31-q33 region, which contains 
the genes encoding for the IL-4, IL-13, and Il-5 cytokines. An association between an IL13 polymorphism, rs1800925, 
and infection levels has been shown. This polymorphism synergistically acts with another polymorphism (rs324013) in 
the STAT6 gene, encoding for the signal transducer of the IL13 pathway. This pathway has also been involved in atopic 
disorders. As helminthiasis, atopy is the result of aberrant Th2 cytokine response to allergens, with an increased produc-
tion of IL-4, IL-13, Il-9 and Il-5, with high amounts of allergen-specific and total IgE and eosinophilia. However, the Th2 
immune response is protective in helminthiasis but aggravating in atopic disorders. Several studies reported interplay be-
tween helminthic infections and allergic reactions. The different results are discussed here.  
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INTRODUCTION 
  Infectious diseases are responsible for 45% of death in 
developing countries (25% of deaths throughout the world). 
Schistosomiasis (or bilharziasis) is the second leading para-
sitic disease behind malaria and  remains a major public 
health problem. Approximately 300 million people are ex-
posed to Schistosoma in 74 countries worldwide with a con-
centration in Asia, Africa, and South America [1]. Each year 
280,000 people die of this disease [2].  
  Schistosomiasis is caused by the digenetic trematode 
Schistosoma. Three main species are pathogenic for humans, 
each one causing a different clinical presentation of the dis-
ease.  Schistosoma mansoni is responsible for hepatic bil-
harziasis,  Schistosoma haematobium leads to urinary bil-
harziasis, and Schistosoma japonicum is responsible for he-
pato-intestinal bilharziasis. Moreover, these three forms pre-
sent different geographical distribution. Infection of Schisto-
soma mansoni ( S.m.) is found in South America (Brazil, 
Venezuela, and Surinam), Africa and the Middle East. Infec-
tion of Schistosoma haematobium ( S.h.) occurs mainly in 
Africa and in the Middle East, while Schistosoma japonicum 
(S.j.) is found in the Far East, mostly in China and the 
Philippines. 
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PARASITE CYCLE  
  Schistosomes have a typical trematode vertebrate-
invertebrate lifecycle Fig. (1). Sexual reproduction of Schis-
tosoma occurs in the definitive host (humans) and asexual 
reproduction occurs in the intermediate hosts (snails). These 
latter hosts are different depending on the Schistosoma spe-
cies. Thus, S.m. penetrates into Biomphalaria spp, S.h. pene-
trates into Bulinus spp. and S.j. infects Oncomelania spp.  
  Fertilized schistosome eggs, delivered in fresh water via 
excrements of infected subjects, hatch after ~10 days and 
release ciliated motile miracidia. Miracidia infect the inter-
mediate hosts by penetrating the foot of the snail. They 
transform into primary sporocysts, which then begin division 
into secondary sporocysts. The secondary sporocysts migrate 
to liver and pancreas and divide again into thousands of lar-
vae termed cercariae, which are capable of infecting mam-
mals. Four to six weeks later, mature cercariae emerge daily 
from snails in a circadian rhythm, depending on ambient 
temperature and light.  
  People are infected by contact with water used in normal 
daily activities (such as washing, wading, fishing, rice culti-
vation…). Young cercariae directly penetrate the body sur-
face by attaching to human skin and by secreting enzymes 
that break down the skin proteins. During this process they 
loose their tail and transform into schistosomules. The schis-
tosomules may remain trapped into the skin for 2 days before 
entering the vasculature and migrating to the lungs. There, 
parasites undergo further developmental changes (8-15 days  
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after infection) and move to the portal circulation and finally 
to the liver, where maturation and mating between males and 
females occur.  
  At this step, the female worm resides in the gynae-
cophoric channel of the male. The worm pairs move against 
the flow of blood into their final niche. Adults S.m. and S.j. 
thus reside in the venous mesenteric plexus, whereas adults 
S.h. reside in the venules of the urinary bladder and ureters. 
Adult worms measure 1-2cm in length and generally live 3-5 
years in the human body, but they may persist up to 20 years. 
Female worms release eggs (300-3000 eggs/days), which 
measure 70-150m in length, within the vasculature. Usu-
ally, these eggs cross the endothelium and basement mem-
brane of the vein and traverse the intervening tissue, such as 
basement membrane and epithelium of the intestine (S.m. 
and S.j.) or bladder (S.h.) in order to be eliminated in urine 
or faeces Fig. (1). 
PATHOPHYSIOLOGY  
  The pathophysiology of Schistosoma  infection can be 
divided into three stages: First, the cutaneous stage is dis-
creet and consists of movement of cercariae through the skin. 
Penetration and migration of cercariae are facilitated by pro-
teolytic enzymes secreted from cephalic glands capable of 
digesting epidermal keratin [3]. Skin reactions (itching) may 
develop within a few hours after infection. A rash may ap-
pear up to one week later.  
  Then, acute schistosomiasis is a clinical syndrome often 
seen in non immune individuals (tourists, immigrants, or the 
indigenous population), who have been exposed in an en-
demic area to a primary infection by cercariae. This syn-
drome is also called Katayama fever [4, 5]. The acute intes-
tinal symptoms due to S.m.  infection appear when adult 
worm pairs release eggs in the tissues. Symptoms include 
diarrhea, which may start suddenly 40-55 days after the pri-
mary infection and may last for 6-12 months.  
  Finally, chronic manifestation of Schistosoma infection 
occurs as a consequence of many years of progressive injury, 
resulting from chronic egg deposition in the tissues [6]. In 
S.m. infection, eggs are swept into the portal circulation and 
can be trapped within the intestinal wall. This phenomenon 
leads to the chronic intestinal disease, during which patients 
complain of abdominal pain. In the S.j. infection, eggs are 
likely deposited along the small portal veins of the peripheral 
part of the liver. This is probably because eggs of S.j. are 
smaller (70-100m) than those of S.m. (110-170m). During 
S.h. infection, the passage of eggs across the bladder wall 
causes damage to this organ. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Parasitic life cycle of Schistosoma mansoni, S. japonicum and S. haematobium adapted from the web site DPDx, which is developed 
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  Eggs trapped in liver are surrounded by the granuloma-
tous inflammatory response of the host (immune response 
benefit to the host if well-controlled) [7-9]. Hepatomegaly 
reflects the presence of granuloma and occurs early in the 
evolution of the chronic disease. The intensity and the dura-
tion of infection determine the amount of antigens released 
and the severity of the disease. The granuloma that is regu-
lated by a variety of cytokines and mediators [10, 11] de-
stroys the eggs but this is sometimes accompanied by exces-
sive fibrous tissue deposition, which concentrates in the pe-
riportal spaces [12] and leads to the development of peripor-
tal fibrosis (Symmers’ fibrosis) [13]. Associated with this 
phenomenon are a periportal hypertension [14], the devel-
opment of ascites and portal-systemic venous shunts, which 
can rupture and lead to life-threatening bleeding. 
  The most serious effects of infection with S.h. are kidney 
dysfunctions, bladder cancer and genital schistosomiasis, in 
which eggs pass through the cervix in women or into the 
testes in men, and which can lead to sterility.  
MULTIPLE FACTORS ARE INVOLVED IN HUMAN 
RESISTANCE TO SCHISTOSOMIASIS 
  Schistosomiasis is a multifactorial disease involving en-
vironmental, behavioral, parasitic, vector and host factors 
[15]. For instance, the number of parasites in infected water 
varies depending on the studied area and is thus one of the 
main environmental factors. For a long time we have thought 
that the most exposed individuals were also the most in-
fected, as determined by fecal egg counts. However, a study 
carried out on a fisherman population from Uganda showed 
that adults, who were more exposed than children because of 
their occupation as fishermen, were less infected than the 
children [16]. Actually, age appeared as an essential host 
factor. Indeed, children younger than 15 years old are gener-
ally more susceptible to infection than adults [17-20]. Thus, 
an acquired protective immunity would appear gradually 
according to the age and exposure by an individual [21]. In 
these conditions an early and repeated exposition to infection 
would lead to an earlier establishment of protection. 
  Sex is another host factor implicated in the control of 
infection, with higher infection levels in males than in fe-
males, which could be explained by reduced infected water 
contact after puberty for women or/and by hormonal factors. 
Moreover in endemic areas of schistosomiasis, it was ob-
served that individuals with the highest infection levels were 
grouped within certain families, rather than randomly dis-
tributed and that certain subjects were clearly predisposed to 
reinfections [15]. This suggested that human resistance to 
infection by Schistosoma may also depend on the effects of 
some genetic factors [15, 22-24]. 
TWO MAJOR LOCI CONTROL HUMAN SUSCEPTI-
BILITY TO SCHISTOSOMIASIS 
  In 1991, Dessein et al. performed segregation analysis, 
the first step to determine the mode of inheritance of a given 
trait from family data, on 20 Brazilian pedigrees (269 indi-
viduals), issued from an endemic area of S.m., in the aim to 
investigate whether a major gene controls human susceptibil-
ity/resistance to infection by Schistosoma [25]. Two different 
models of analysis were used: the unified mixed model and 
the regressive model, and relevant factors for schistosomia-
sis, such as water contact, sex and age were taken into ac-
count. Results showed that the best model to explain the in-
heritance of the control of infection by Schistosoma was the 
existence of a codominant major gene. This gene accounts 
for 66% of the infection intensity variances residual from 
covariate effects. The deleterious allele occurs with a fre-
quency of 0.16. This frequency correlates with 3% of the 
population homozygous for the allele and thus predisposed 
to high infections, 27% of the population heterozygous with 
an intermediate level of infection, and 70% of the population 
resistant. These findings provide a genetic basis for earlier 
observations on the lower resistance and the predisposition 
to reinfection of some individuals. 
 Marquet  et al. (1996) showed that variations of infection 
levels with age cannot be fully explained by changes in wa-
ter contact [26]. Indeed infection levels adjusted for water 
contact increased markedly between the time of first contact 
(~ age 2 to 3) and puberty, and then declined during adoles-
cence, which correlates with the view of an assumption of 
gradual acquisition of immunity during childhood. 
  To localize the major gene involved in the control of in-
fection by Schistosoma, referred as SM1, the authors also 
carried out a genome-wide study on 142 Brazilian subjects 
belonging to 11 informative families (2 large pedigrees, 5 
smaller pedigrees and 4 nuclear families). In a primary map 
(246 markers; interval of 15cM between adjacent markers), 
two adjacent markers on chromosome 5q31-33, D5S393 and 
D5S410, provided lod scores greater than 1.9, indicating a 
suggestive linkage [26]. Therefore, 11 additional markers in 
this region were analysed. Significant evidence of linkage 
(Z>3.3) was obtained with 2 proximal markers: D5S636 
(Zmax=+4.74, =0.07) and the Colony Stimulating Factor-1 
Receptor (CSF1R) (Zmax=+4.52, =0.04). Refined mul-
tipoint analysis of the region confirmed that the most likely 
location of SM1 was in close proximity to CSF1R, with a 
Zmax=+5.45 observed between CSF1R and D5S636 [26]. 
This result was confirmed later in an independent study done 
in a Senegalese population living in an endemic area for S.m. 
[27]. 
  This region contains several candidate genes involved in 
the regulation of the immune response to pathogens, such as 
the genes encoding for the interleukins 4 (IL-4), IL-5, IL-9, 
and IL-13 [28], all known to induce an anti-inflammatory 
Th2 response. The region also contains the gene encoding 
for the IL12p40 subunit common to the proinflammatory 
cytokines IL12 and IL23 [29]; the Interferon Regulatory Fac-
tor 1 (IRF1), which encodes a transcriptional activator of 
interferon- (IFN-), interferon- (IFN-) and other IFN-
inducible genes [30]; and finally the Colony-Stimulating 
Factor 1 Receptor (CSF1R) gene [31]. Furthermore, the 
5q31-q33 region has already been associated with the regula-
tion of IgE levels [32], to familial eosinophilia [33], asthma 
[34],  Plasmodium falciparum blood infection levels [35], 
and more recently, to inflammatory bowel diseases [36]. 
 Marquet  et al. found that four additional markers in three 
other regions provided interesting lod-score values above 
0.83: 1p22.2 with D1S216 (Zmax=+0.91, =0.20), 21q22-
qter with D21S1259 (Zmax=+1.09, =0.19) and the two ad-
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(Zmax=+1.02, =0.22) in the 7q36 region [26, 37]. Although 
these values are not significant in the context of a genome 
wide search, these regions contain some interesting candi-
date genes. The IL12 receptor 2 chain gene is located close 
to the 1p22.2 region [38], and plays an important role in the 
regulation of the Th1-type immune response. The interferon-
 receptor (IFN-R) and interferon  receptor (IFN-R) 
genes, both inhibitors of IL-12 and INF-, are located in 
21q22-qter [39]. Finally, the beta T cell receptor (TCR) 
gene maps closed to the 7q36 region [40].  
 Dessein  et al. (1999) showed that genetic factors were 
involved in the control of severe disease caused by Schisto-
soma  [14, 41]. This work was carried out in a Sudanese 
population free of treatment and living in a region endemic 
for  S.m.. Fibrosis was evaluated by ultrasound, liver size, 
peripheral portal vein branches (PPBs), spleen size, and 
splenic and portal vein diameter (PVD). Periportal fibrosis 
was graded 0 to 3 as suggested by the Niamey working 
Group. 
  Several observations have suggested that inherited fac-
tors might play a role in advanced fibrosis in this Sudanese 
population, such as elevated frequency of advanced fibrosis 
in certain families, despite similar epidemiological condi-
tions for the whole study population and that fibrosis grades 
correlated only between parents and children but not among 
spouses. Dessein et al. performed a segregation analysis on 
781 subjects (361 males, 420 females) belonging to 65 pedi-
grees [14]. The hypothesis of no familial dependence was 
rejected, and sib-sib dependence was not significant. The 
results showed that a codominant major gene referred to as 
SM2 accounts for the familial distribution of the phenotype 
defined as hepatic fibrosis and portal hypertension in schis-
tosomiasis. The frequency of the deleterious allele A was 
estimated as 0.162. Therefore, the proportions of AA, Aa 
and aa subjects were 0.03, 0.27and 0.70 respectively. 
  To localize SM2, the authors genotyped all the informa-
tive families with multiple cases of severe fibrosis (8 fami-
lies including 112 individuals) and linkage analysis was done 
in four candidate regions: (1) the 5q31-q33 region were SM1 
and several candidate genes are localized; (2) the HLA-TNF 
region (6p21) containing the HLA locus and the genes cod-
ing for TNF- and TNF-; (3) the 12q15 region including 
the gene coding for IFN and a gene controlling total serum 
IgE levels; (4) the 6q22-q23 region containing the IFNR1 
gene. No significant results were found in the 5q31-q33, the 
6p21 and the 12q15 regions. However significant Zmax val-
ues were observed in the 6q22-q23 region, with both 
D6S310 (Zmax=2.81, =0.0) and the FA1 intragenic marker 
(Zmax=1.80, =0.0) [41]. 
IMMUNE RESPONSE ASSOCIATED TO INFECTION 
  In the murine model, several reports showed that a down-
regulation of Th1 cytokine production and an induction of a 
Th2 response lead to a high IgE levels. Moreover, high num-
bers of peripheral eosinophils were associated with a poor 
clinical outcome [42].  
  In humans, analysis of the immune response of individu-
als with different levels of resistance were done to under-
stand the principal mechanisms of resistance and to identify 
their targets on the parasite. Rihet et al. (1991) evaluated 
IgE-dependent immunity in subjects with high resistance to 
infection. They observed that IgE levels remained relatively 
steady during the whole study, while subjects experienced 
large variations in infection intensities, indicating that 
aborted or low infections are sufficient to maintain high IgE 
levels. They also showed that IgE bound to a large variety of 
S.m. antigens. Some of them were on the outer part of the 
schistosomule membrane, suggesting that these parasitic 
regions were putative targets of IgE-dependent cell-mediated 
cytotoxicity against the invading larvae. Finally, they dem-
onstrated that IgE levels were higher in the most resistant 
subjects than in the less resistant ones [43]. All these obser-
vations are consistent with the fact that IgE play a significant 
role in human immune defenses against S.m. infections. It 
has also been reported that human eosinophils, purified from 
patients infected with S.m., expressed three different types of 
IgE receptors: the high affinity Fc- receptor (Fc- RI), the 
low-affinity Fc- receptor (Fc- RII/CD23) and Mac-2/ BP 
[44-46]. 
  In the aim to resolve contradictory findings concerning 
acquired immunity between mice and humans, Nyindo et al. 
(1999) used baboons as an experimental model [47]. Non-
human primates and particularly the olive baboon (Papio 
cynocephalus anubis) have several advantages over rodents. 
Indeed, in East Africa, S.m. infects wild populations of olive 
baboons and can sustain transmission removed from human 
contacts. Baboons are highly susceptible to experimental 
infections as well. The proportion of penetrating cercariae 
that mature to adult worms often exceeds 90%, whereas cer-
carial infectivity in mice rarely surpasses 50%. Natural infec-
tion as well as immunization with irradiated cercariae or 
recombinant antigens of schistosomes, produce partial resis-
tance to challenge infection in baboons. The pathologies in 
baboons closely resemble human infection in that the ba-
boons acquire immediate hypersensitivity responses to schis-
tosomes’ antigens. In an initial experiment, animals were 
exposed to single or multiple infections and were subse-
quently cured with praziquantel prior to challenge with an-
other infection. Singly and multiply infected animals 
mounted reductions in worm burden. In a second experi-
ment, animals were inoculated with S.m. ova and recombi-
nant human interleukin 12. This produced a reduction in 
adult worm burden after challenge. Parasite-specific IgG, 
IgE, IgM, and peripheral blood cytokine production were 
evaluated. The only immune correlate of protection in both 
experiments was levels of soluble adult worm antigen 
(SWAP)-specific IgE in serum at the time of challenge infec-
tion and/or 6 weeks later [47]. Thus, in baboons and not in 
mice, adult worm-specific IgE is uniquely associated with 
acquired immunity to S.m. infection.  
  Finally the best and the most used experimental model of 
infection by Schistosoma was shown to be the rat. The rat is 
a semi-permissive host to S.m. infection, as it can reject 
worms between 3 and 4 weeks after a primary infection, and 
develop immunity to reinfections [48, 49]. In this experimen-
tal model, humoral immunity plays a major role, whereas the 
cell-mediated immunity does not [48, 49]. Thus, the rat was 
used to identify the antibody isotypes involved in the anti-
body-dependant cellular cytotoxicity (ADCC). First, it was 
shown that the anaphylactic antibodies IgG2a and IgE en-
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cytotoxicity was enhanced by mast cells, which release solu-
ble factors that activate eosinophils [50]. Then, the use of 
monoclonal antibody isotypes IgG2a and IgE, as well as 
eosinophils primed with cytophilic IgE, confirmed these ob-
servations [51, 52]. Among the monoclonal antibodies pro-
duced, IgG2c was not cytotoxic but was able to inhibit the in 
vitro effects of IgG2a, by blocking eosinophil degranulation 
and cell-mediated cytotoxicity [53, 54]. Moreover, Dom-
browicz et al. (2000) demonstrated that in rats, as in humans, 
eosinophils and macrophages expressed a functional alpha 
gamma 2 trimeric Fc- RI and that these two cell types could 
induce IgE-mediated, Fc- RI-dependent cellular cytotoxic-
ity toward schistosomules [55]. 
  A similar isotypic regulation happens in human infection. 
First, Khalife et al. (1986) showed that high levels of the 
IgM isotype were associated with schistosomiasis reinfection 
in children classified as susceptible to posttreatment reinfec-
tion. This was determined to be due to IgM blockade of 
eosinophil-dependent cytotoxicity [56]. Likewise, Hagan et 
al. (1991) demonstrated a correlation between IgG4 isotypes 
and a strong susceptibility to reinfections [57]. IgG4 antibod-
ies block eosinophily-mediated killing that is aided by IgG 
effector antibodies, such as IgG1 and IgG3. In addition, 
IgG2 antibodies mediate activated eosinophil effector func-
tion but block normal eosinophil function. These results 
were confirmed by Demeure et al. (1993) who found a posi-
tive association for IgE and negative associations for IgG2 
and IgG4 with resistance to reinfection after chemotherapy. 
The opposing effects of IgE and IgG4 were undissociable in 
the analysis, suggesting that these isotypes antagonize each 
other in protection [58].  
  As IgE and eosinophils are highly dependent on IL-4, Il-
5 and IL-13, it was thought that protection against infection 
by  Schistosoma would involve a Th2 immune response. 
Therefore Couissinier-Paris et al. (1995) asked whether hu-
man resistance to S.m. was associated with a particular T 
helper subset. They isolated twenty-eight CD3
+, CD4
+, CD8
- 
parasite-specific T cell clones from three adults with high 
degree of resistance to infection by S.m.. The lymphokine 
secretion profiles of these clones were determined and com-
pared to those of 21 CD3
+, CD4
+, CD8
- clones with un-
known specificity, established from these same subjects in 
the same cloning experiment. They found that the parasite-
specific T cell clones isolated from adults resistant to S.m. 
produced large amounts of IL-4 and IFN- and belong to the 
Th0 subset. However they produced more IL-4 than IFN- 
(Th0/2). They then compared parasite-specific T cell clones 
from the resistant subjects to specific T cell clones from a 
sensitized adult living in a nonendemic area: they showed 
that these latter clones were also Th0 but produced more 
IFN- than IL-4 (Th0/1) [59]. 
  As highlighted above, human susceptibility to S.m. infec-
tions is controlled by the SM1 locus in the 5q31-q33 region. 
This genetic region encodes several cytokines that regulate 
the differentiation of Th1 and Th2 lymphocytes. Rodrigues 
et al. (1999) reported that they had performed a clonal analy-
sis of CD4
+ T lymphocytes in resistant and susceptible sub-
jects to evaluate whether this genetic control is acting on 
Th1/Th2 pathways. The subjects evaluated were either ho-
mozygous for the allele that determines resistance to infec-
tion or were homozygous for the allele that determines high 
rates of infection. Of 121 CD4
+ T cell clones (TCC) from 
three susceptible and three resistant subjects, 68 were para-
site-specific (spTCC). The spTCC derived from susceptible 
subjects (33 STCC) produced 10- to 1000-fold less IL-4 and 
IL-5 than TCC from resistant subjects (25 RTCC). However 
clones from both patient groups produced the same amount 
of IFN-. Parasite-specific STCC were Th1 or Th0/1, where- 
as RTCC were Th2 or Th0/2. These results indicated that the 
SM1 locus controls the differentiation of Th2 lymphocytes 
[60]. 
IL13 GENE IS ESSENTIAL TO THE CONTROL OF 
INFECTION LEVELS IN SCHISTOSOMIASIS 
  Infection levels by Schistosoma are controlled by a major 
locus on chromosome 5q31-q33 containing the IL4, IL5 and 
IL13 genes related to the Th2 immune response [26]. As 
previous studies have shown that sterile immunity in schis-
tosomiasis is dependent on IgE levels, eosinophils and on the 
Th1/Th2 balance, our laboratory decided to test whether any 
allelic variants in the IL4, IL5 and IL13 genes would predis-
pose individuals to high infection levels by Schistosoma 
[61]. A genetic association study was performed on a Malian 
population localized in two villages, Ségué and Boul, where 
S.h. is endemic (693 subjects in Ségué and 148 in Boul). 
Schistosoma infection levels were evaluated either by count-
ing eggs in urine or by circulating worm antigens (CAA) in 
serum. We focused on areas of the promoter regions of IL4, 
IL5 and IL13 genes that contain transcriptional regulatory 
elements. Genotyping of the polymorphisms by restriction 
enzyme analysis or by primer extension and denaturing high-
performance liquid chromatography analysis defined one 
polymorphism in the IL4 promoter (IL4-590C/T), one in the 
IL5 promoter (IL5-202G/A) and three polymorphisms in the 
IL13 promoter (IL13-1258A/G, IL13-1055C/T (rs1800925) 
and IL13-591A/G (rs2069743)). We also added the func-
tional polymorphism in asthma, IL13Arg130Gln, to the 
analysis [62].  
  Initially, a family-based study was performed to deter-
mine if one of the tested allele was preferentially transmitted 
to highly infected children [61]. In this case, the associated 
polymorphism would be located close to the susceptibility 
gene. A trend for an association for the polymorphism 
rs1800925 in an additive model was observed (p=0.05). In a 
recessive model, rs2069743 also shown an association 
(p=0.003). These results suggested that alleles rs1800925C 
and rs2069743A may predict an increased risk of infection 
Fig. (2A). A multivariate analysis was then performed be-
tween IL13 polymorphisms and high infection levels, taking 
into account age, gender and the village of origin. Age 
(p<10
-3), gender (p<10
-3), village (p<10
-3) and rs1800925 
(p=0.04) were all significantly associated with infection lev-
els, while rs2069743 was rejected by the analysis. This asso-
ciation was even stronger when the analysis was limited to 
the highest infected village Boul (p=0.002). Genotypes 
rs1800925C/C and C/T were associated with the highest in-
fection levels, whereas the T/T genotype was associated with 
the lowest infection levels Fig. (2C).  
  However the rs1800925 genotype effect could be due to 
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vae. To determine which of these hypotheses was correct, an 
association between rs1800925 genotypes and the high CAA 
concentrations was evaluated. The rs1800925T/T genotype 
was associated with lower CAA concentrations than the two 
other genotypes. To further test these results, a multivariate 
analysis was performed, including other variables known to 
affect CAA levels. A trend (p=0.01) was found again for an 
association between rs1800925 genotypes and CAA levels 
when taking into account age (p<10
-3) and the village of ori-
gin (p<10
-3). The other variables were excluded by the 
analysis. Once again, when the study was limited to Boul, 
the association became stronger (p=0.02). Thus, the 
rs1800925 genotypes are also associated with worm load, 
with the rs1800925T/T subjects having the lowest worm 
load. Collectively, these results suggest that IL-13 may be 
involved in protective immunity against both larvae and 
eggs.  
  The rs1800925 polymorphism has been demonstrated to 
be functional in a study dealing with allergic asthma [63]. 
The authors showed that the rs1800925T/T genotype was 
more frequent in allergic asthma patients (n=101) than in 
non-atopic controls (n=107) (p=0.002, OR=7.8). T cell IL-13 
production is usually inhibited by a calcium-inducing signal, 
which can be reversed by CsA. They also showed that the 
T/T genotype was associated with a decreased relative inhi-
bition of IL-13 production compared to the C/C (p=0.0016) 
or the C/T (p=0.0002) genotypes, as well in the patient group 
and in the control group. Finally they completed these obser-
vations by demonstrating that the change of the rs1800925C 
to the T allele increases the binding of transcription factors, 
such as NF-AT. Therefore, in the absence of CsA, known to 
prevent nuclear translocation of NF-AT through inhibition of 
the calcium-dependent phosphatase calcineurin, calcineurin 
activates NF-AT by dephosphorylation resulting in NF-AT 
translocation to the nucleus where it binds to specific DNA 
sequences that control gene transcription. The authors specu-
lated that the binding of NF-AT to the IL-13 promoter inhib-
its IL-13 production.  
  A more recent study [64] reported on the analysis of the 
functional impact of this polymorphism according to the cell 
type. The authors showed that the T allele enhanced the IL13 
promoter activity in primary human and murine CD4+ Th2 
cells. The presence of this allele correlates with a Ying-Yang 
1 factor (YY1) binding site but this site overlaps a STAT6 
binding site which seems to inhibit the expression of the IL-
13. Thus, binding of YY1 would inhibit the activity of 
STAT6, which would lead to increased IL-13 expression. 
They also confirmed that the rs1800925T/T homozygotes 
had a greater expression of IL-13, indicating that this in vivo 
genotype should be associated with susceptibility to allergic 
inflammation. Interestingly, in non-polarized CD4+ T cells, 
the rs1800925T allele caused the fixation of NF-AT2 in ad-
dition to those already reported above resulting in an oppo-
site transcriptional effect. 
STAT6 POLYMORPHISM HAS SYNERGIC A EF-
FECT WITH IL13 POLYMORPHISM 
  The bronchial pathology in asthma and the protective 
host response to helminth include main elements of Th2 im-
mune activity, which lead to increased mucosal eosinophil 
activity, mucus hypersecretion, and muscle hyperactivity. 
However, in the bronchus, these features correspond to the 
symptoms of chronic asthma, while in the gut these immune 
mechanisms promote the expulsion of helminths. Common 
upregulating genetic variants of Th2 immune signaling are 
risk factors for asthma and it was hypothesized that they may 
confer a counteradvantage in promoting protective Th2 im-
mune response against helminth infection. 
 Peisong  et al. (2004) tested whether Th2 risk polymor-
phisms for asthma were also associated to protection against 
the helminth worm Ascaris lumbricoides, in a Chinese popu-
lation of 614 schoolchildren (11-15 years old). By logistic 
regression, they found a major association between a com-
mon genetic variant of the 3’-UTR regulatory elements 
(+4219G/A) of the Signal Transducer and Activator of Tran-
scription 6 (STAT6) and egg counts (p=0.0002). Linear re-
gression after log transformation of egg counts confirmed a 
highly significant association with this STAT6 variant 
(p=0.001). They thus demonstrated that an asthma-associated 
risk polymorphism in STAT6, one of the main transcription 
factors in the Th2 signaling pathway, predicts increased re-
sistance to ascaris worm infection [65].  
  These observations suggested that several genes encod-
ing the main components of the Th2 pathway could have 
significant effects on Schistosoma infection. Recently, we 
decided to test whether any allelic variants of the major Th2 
genes were associated with the control of S.h. infection lev-
els. These studies were performed on samples from the same 
Malian population. We analyzed 18 polymorphisms con-
tained in IL4 (a major Th2 cytokine), IL4RA (the common 
receptor chain for IL-4 and IL-13), IL13RA1, IL13RA2 (both 
the receptor chains for IL-13), STAT6 (the signal transducer 
activated by the IL-4/IL-13 pathway) and GATA3 (a major 
factor in determining Th1/Th2 responses) genes by multi-
variate analysis (linear logistic regression) [66].  
  We found a trend (p=0.04) of association for only one 
polymorphism, rs324013, localized in the STAT6 gene pro-
moter, taking into account age (p<10
-3) and gender (p<10
-3). 
The genotype rs324013C/T was found in subjects with 
higher levels of infection than subjects carrying the C/C or 
T/T genotypes Fig. (2B). This effect was more significant in 
the village with the highest levels of infection, (Boul Fig. 
(2D)), and in subjects under 20 years old. A separate linear 
regression analysis for subjects under 20 years old and from 
Boul showed a significant association between rs324013C/T 
and the highest infection levels (p=0.005).  
  In order to characterize the involvement of IL13 and 
STAT6 polymorphisms, a new multivariate analysis was 
done. Gender (p<10
-3), rs324013 (p=0.017) and rs1800925 
(p=0.027) were all associated with infection levels. The addi-
tive effect of these two polymorphisms was illustrated by 
subjects from Boul with the genotypes rs1800925C/C and 
rs324013C/T having higher levels of infection than subjects 
carrying the other genotypes Fig. (2E-F). A linear regression 
analysis confirmed the association of these two genotype 
combinations with infection levels (p=0.011).  
  We then checked whether these two SNPs directly af-
fected infection levels or were correlated with the causative 
polymorphisms. We thus defined the correlation groups, 296    Current Genomics, 2008, Vol. 9, No. 5  Isnard and Chevillard 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). A: rs1800925T is associated with protection against infection by Schistosoma haematobium in the whole Malian study population. 
Infection levels were quantified by counting eggs in urine. Individual infection levels are the arithmetic mean egg counts on three to seven 
samples. To ensure quality control of the egg count, 10% of the filters were randomly selected and recounted by another microscopist. B: 
rs324013C/T is associated with high levels of infection caused by Schistosoma haematobium in the whole Malian study population. C: 
rs1800925T is stronger associated with protection against infection by Schistosoma haematobium, when taking into account only the most 
infected village, Boul. D: rs324013C/T is stronger associated with high levels of infection caused by Schistosoma haematobium, when con-
sidering only the most infected village, Boul. E: rs1800925 and rs324013 have additive effects on the regulation of infection levels caused by 
Schistosoma haematobium, when considering only the most infected village, Boul.  
F: rs1800925 and rs324013 have better additive effects on the regulation of infection levels caused by Schistosoma haematobium, when tak-
ing into account only the population younger than 16 years old, and coming from the most infected village, Boul.  Recent Advances in the Characterization of Genetic Factors  Current Genomics, 2008, Vol. 9, No. 5    297 
 
based on r squared values, in the 5q31 region surrounding 
the IL13 gene and the 12q13 region surrounding the STAT6 
gene. We found that rs1800925 (0<r
2<0.22) and rs324013 
(0.03<r
2<0.24) were not strongly correlated with any other 
tested markers, indicating that they are likely to be the causa-
tive polymorphisms involved in the control of infection by 
Schistosoma. Finally, as both polymorphisms are localized in 
the promoter of their own gene, we performed gel shift assay 
to test if these allelic variants modify the binding of tran-
scription factors depending on the present allele. We con-
firmed that rs1800925 changes the binding of transcription 
factors in PHA-stimulated PBMCs nuclear extracts and in 
CD4
+ T cells nuclear extracts. We also demonstrated a dif-
ferential binding for rs324013 in PHA-stimulated PBMCs, 
confirming thus that these two polymorphisms are func-
tional. All these data are in agreements with the properties of 
IL-13 Fig. (3) and STAT6 proteins Fig. (4). 
HELMINTH, ASTHMA AND ALLERGY 
  Helminthiases and atopic disorders are closely linked. 
Indeed, both helminthic parasites and many allergens trigger 
highly polarized Th2-type immune responses. However, 
while in helminth infections this kind of immune response 
often leads to the worm expulsion or sequestration, in atopy 
it leads to severe allergic phenotypes. Several groups studied 
the effects of helminthic infections in allergic patients or the 
allergic reactions in patients infected by helminths.  
 Lynch  et al. evaluated the influence of atopy on the anti-
parasite response in two groups of Venezuelan children, liv-
ing in an endemic region for the intestinal helminth Ascaris 
lumbricoides, but differing greatly on their level of atopy, 
depending on whether they live on an island or in a mainland 
population [67]. They found that the intensity of the parasitic 
infection was considerably higher in the nonatopic mainland 
children than in the atopic island group, but with a ratio of 
anti-Ascaris specific to total IgE levels significantly more 
elevated in the atopic island subjects than in the nonatopic 
children. The atopic children seemed thus to have an intrin-
sic capacity to favor specific over polyclonal IgE responses 
concordant with an enhanced protective response against 
helminthic parasites. 
 Araujo  et al. (2000) showed that in a region endemic of 
schistosomiasis (S.m.), there were a higher proportion of 
allergic individuals in the uninfected group than in the in-
fected one, with a risk of developing atopy higher in the un-
infected group [68]. They also found that the total and S.m. 
specific IgE levels were higher in infected group, whereas 
the aeroallergen-specific IgE were higher in the uninfected 
group. Therefore they demonstrated a strong and significant 
inverse association between the immediate skin test response 
to common aeroallergens and infection by S.m.. Van den 
Biggelaar  et al. (2000) confirmed these results in a study 
performed on a Gabonese population in which they found 
that children with urinary schistosomiasis (S.h.) had a lower 
prevalence of a positive skin reaction to house-dust mite than 
those uninfected [69]. Moreover, Medeiros et al. (2003) 
evaluated the influence on S.m. on the course of asthma [70]. 
They thus compared 3 groups of Brazilian asthmatic pa-
tients, issued either from a rural area endemic for S.m. or 
from non-endemic rural or slum areas, and matched accord-
ing to their age and gender. Once again, they found a signifi-
cantly milder form of asthma in the infected subjects. It is 
noteworthy that the protective effect of schistosomes on 
atopic disorders can happen in genetically different people 
from 2 continents (Africa and South-America) and that, at 
least, two species of Schistosoma can be involved.  
  Afterwards, several studies on children who had various 
chronic intestinal helminth infections in several developing 
countries, such as Ethiopia [71], Gambia [72], Taiwan [73] 
and Ecuador [74], confirmed the link between the Th2 im-
mune responses, the chronic intestinal helminth infections 
and the reduced prevalence of allergic disorders. Further-
more it has been shown in various studies that the use of 
anthelminthics in infected subjects to remove worms in-
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Multiple roles of the IL-13 in the protection against infection by Schistosoma. 298    Current Genomics, 2008, Vol. 9, No. 5  Isnard and Chevillard 
creased their atopic reactivity to different allergens within ~2 
years after treatment, raising the fact that the presence of 
helminths could actively suppress allergic reactions. How-
ever, the link between asthma/atopy and helminth infections 
was not clearly found in three other studies [75-77] indicat-
ing that this disease relationship is highly complex.  
  Finally, the recent advances in our knowledge of how 
genetic factors control the infection in schistosomiasis allow 
us to better understand the pathologic mechanisms of the 
disease. Thanks to these findings, we will be able to define 
new targets and hopefully to develop more efficient methods 
for diagnostics, therapies and vaccine.  
ACKNOWLEDGEMENTS 
  This work was supported by funding from Institut Na-
tional de la Santé et de la Recherche Médicale, the World 
Health Organization (ID096546 and A20380), the European 
Economic Community (TS3 CT940296, IC18CT970212), 
the Scientific and Technical Cooperation with Developing 
Countries (IC18CT980373), the French Ministere de la Re-
cherche et des Techniques (Programme de Recherche Fon-
damentale en Microbiologie, Maladies Infectieuses, et Para-
sitaires), the Conseil Général Provence Alpes Côte d’Azur, 
and the Conseil Régional Provence Alpes Côte d’Azur, the 
University Aix-Marseille II, the Faculty of Medecine Ti-
mone Marseille and the French and Chinese Association 
(PRA B02-01). The authors would also like to thank Debbie 
Hodge and Bane Schill for English correction of this manu-
script. 
REFERENCES 
[1]  Chitsulo, L., Engels, D., Montresor, A., Savioli, L. The global 
status of schistosomiasis and its control. Acta Trop. 2000, 77: 41-
51. 
[2]  van der Werf, M. J., de Vlas, S. J., Brooker, S., Looman, C. W., 
Nagelkerke, N. J., Habbema, J. D., Engels, D. Quantification of 
clinical morbidity associated with schistosome infection in sub-
Saharan Africa. Acta Trop. 2003, 86: 125-139. 
[3]  Fukuyama, K., Tzeng, S., McKerrow, J., Epstein, W. L. The epi-
dermal barrier to Schistosoma mansoni infection. Curr. Probl. 
Dermatol. 1983, 11: 185-193. 
[4]  Rabinowitz, D. The Katayama syndrome, the early allergic stage of 
bilharziasis. S. Afr. Med. J. 1958, 32: 658-660. 
[5]  Farid, Z., Trabolsi, B., Hafez, A. Acute schistosomiasis mansoni 
(Katayama syndrome). Ann. Trop. Med. Parasitol. 1986, 80: 563-
564. 
[6]  Boros, D. L. Immunopathology of Schistosoma mansoni infection. 
Clin. Microbiol. Rev. 1989, 2: 250-269. 
[7]  Peterson, W. P., Von Lichtenberg, F. Studies on granuloma forma-
tion. IV. In vivo antigenicity of schistosome egg antigen in lung tis-
sue. J. Immunol. 1965, 95: 959-965. 
[8]  von Lichtenberg, F., Raslavicius, P. Host response to eggs of Schis-
tosoma mansoni. V. Reactions to purified miracidia and egg shells 
and to viable and heat-killed whole eggs. Lab. Invest. 1967, 16: 
892-904. 
[9]  Warren, K. S., Domingo, E. O., Cowan, R. B. Granuloma forma-
tion around schistosome eggs as a manifestation of delayed hyper-
sensitivity. Am. J. Pathol. 1967, 51: 735-756. 
[10]  Gressner, A. M. Cytokines and cellular crosstalk involved in the 
activation of fat-storing cells. J. Hepatol. 1995, 22: 28-36. 
[11]  Poli, G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol. 
Aspects Med. 2000, 21: 49-98. 
[12]  Grimaud, J. A., Borojevic, R. Chronic human schistosomiasis man-
soni. Pathology of the Disse's space. Lab. Invest. 1977, 36: 268-
273. 
[13]  Symmers, W. Note on a new form of liver cirrhosis due to the 
presence of the ova of Bilharzia hematobia. J. Pathol. 1904,  9: 
237-239. 
[14]  Mohamed-Ali, Q., Elwali, N. E., Abdelhameed, A. A., Mergani, 
A., Rahoud, S., Elagib, K. E., Saeed, O. K., Abel, L., Magzoub, M. 
M., Dessein, A. J. Susceptibility to periportal (Symmers) fibrosis in 
human schistosoma mansoni infections: evidence that intensity and 
duration of infection, gender, and inherited factors are critical in 
disease progression. J. Infect. Dis. 1999, 180: 1298-1306. 
[15]  Dessein, A. J., Couissinier, P., Demeure, C., Rihet, P., Kohlstaedt, 
S., Carneiro-Carvalho, D., Ouattara, M., Goudot-Crozel, V., 
Dessein, H., Bourgois, A., Abel, L., Carvalho, E.M., Prata, A. En-
vironmental, genetic and immunological factors in human resis-
tance to Schistosoma mansoni. Immunol. Invest. 1992, 21: 423-453. 
[16]  Kabatereine, N. B., Vennervald, B. J., Ouma, J. H., Kemijumbi, J., 
Butterworth, A. E., Dunne, D. W., Fulford, A. J. Adult resistance to 
schistosomiasis mansoni: age-dependence of reinfection remains 
constant in communities with diverse exposure patterns. Parasitol-
ogy 1999, 118(Pt 1): 101-105. 
[17]  Wilkins, H. A., Goll, P. H., Marshall, T. F., Moore, P. J. Dynamics 
of Schistosoma haematobium infection in a Gambian community. 
III. Acquisition and loss of infection. Trans. R. Soc. Trop. Med. 
Hyg. 1984, 78: 227-232. 
[18]  Wilkins, H. A., Goll, P. H., Marshall, T. F., Moore, P. J. Dynamics 
of Schistosoma haematobium infection in a Gambian community. I. 
 
 
 
 
 
 
 
 
 
Fig. (4). Different roles of STAT6 in the protection against infection by Schistosoma and in the regulation of the gene expression in the Th2 
locus. Recent Advances in the Characterization of Genetic Factors  Current Genomics, 2008, Vol. 9, No. 5    299 
The pattern of human infection in the study area. Trans. R. Soc. 
Trop. Med. Hyg. 1984, 78: 216-221. 
[19]  Bradley, D. J., McCullough, F. S. Egg output stability and the 
epidemiology of Schistosoma haematobium. II. An analysis of the 
epidemiology of endemic S. haematobium.  Trans. R. Soc. Trop. 
Med. Hyg. 1973, 67: 491-500. 
[20]  Warren, K. S. Regulation of the prevalence and intensity of schis-
tosomiasis in man: immunology or ecology? J. Infect. Dis. 1973, 
127: 595-609. 
[21]  Anderson, R. M., May, R. M. Helminth infections of humans: 
mathematical models, population dynamics, and control. Adv. 
Parasitol. 1985, 24: 1-101. 
[22]  Butterworth, A. E., Capron, M., Cordingley, J. S., Dalton, P. R., 
Dunne, D. W., Kariuki, H. C., Kimani, G., Koech, D., Mugambi, 
M., Ouma, J. H., Prentice, M.A., Richardson, B.A., Arap Siongok, 
T.K., Sturrock R.F., Taylor, D.W. Immunity after treatment of hu-
man Schistosomiasis mansoni. II. Identification of resistant indi-
viduals, and analysis of their immune responses. Trans. R. Soc. 
Trop. Med. Hyg. 1985, 79: 393-408. 
[23]  Dessein, A. J., Begley, M., Demeure, C., Caillol, D., Fueri, J., dos 
Reis, M. G., Andrade, Z. A., Prata, A., Bina, J. C. Human resis-
tance to Schistosoma mansoni is associated with IgG reactivity to a 
37-kDa larval surface antigen. J. Immunol. 1988, 140: 2727-2736. 
[24]  Abel, L., Dessein, A. Genetic predisposition to high infections in 
an endemic area of Schistosoma mansoni.  Rev. Soc. Bras. Med. 
Trop. 1991, 24: 1-3. 
[25]  Abel, L., Demenais, F., Prata, A., Souza, A. E., Dessein, A. Evi-
dence for the segregation of a major gene in human susceptibil-
ity/resistance to infection by Schistosoma mansoni. Am. J. Hum. 
Genet. 1991, 48: 959-970. 
[26]  Marquet, S., Abel, L., Hillaire, D., Dessein, H., Kalil, J., Feingold, 
J., Weissenbach, J., Dessein, A. J. Genetic localization of a locus 
controlling the intensity of infection by Schistosoma mansoni on 
chromosome 5q31-q33. Nat. Genet. 1996, 14: 181-184. 
[27]  Muller-Myhsok, B., Stelma, F. F., Guisse-Sow, F., Muntau, B., 
Thye, T., Burchard, G. D., Gryseels, B., Horstmann, R. D. Further 
evidence suggesting the presence of a locus, on human chromo-
some 5q31-q33, influencing the intensity of infection with Schisto-
soma mansoni. Am. J. Hum. Genet. 1997, 61: 452-454. 
[28]  Sutherland, G. R., Baker, E., Callen, D. F., Hyland, V. J., Wong, 
G., Clark, S., Jones, S. S., Eglinton, L. K., Shannon, M. F., Lopez, 
A. F., Vadas, M.A. Interleukin 4 is at 5q31 and interleukin 6 is at 
7p15. Hum. Genet. 1988, 79: 335-337. 
[29]  Sieburth, D., Jabs, E. W., Warrington, J. A., Li, X., Lasota, J., 
LaForgia, S., Kelleher, K., Huebner, K., Wasmuth, J. J., Wolf, S. F. 
Assignment of genes encoding a unique cytokine (IL12) composed 
of two unrelated subunits to chromosomes 3 and 5. Genomics 1992, 
14: 59-62. 
[30]  Itoh, S., Harada, H., Nakamura, Y., White, R., Taniguchi, T. As-
signment of the human interferon regulatory factor-1 (IRF1) gene 
to chromosome 5q23-q31. Genomics 1991, 10: 1097-1099. 
[31]  Le Beau, M. M., Westbrook, C. A., Diaz, M. O., Larson, R. A., 
Rowley, J. D., Gasson, J. C., Golde, D. W., Sherr, C. J. Evidence 
for the involvement of GM-CSF and FMS in the deletion (5q) in 
myeloid disorders. Science 1986, 231: 984-987. 
[32]  Meyers, D. A., Postma, D. S., Panhuysen, C. I., Xu, J., Amelung, P. 
J., Levitt, R. C., Bleecker, E. R. Evidence for a locus regulating to-
tal serum IgE levels mapping to chromosome 5. Genomics 1994, 
23: 464-470. 
[33]  Rioux, J. D., Stone, V. A., Daly, M. J., Cargill, M., Green, T., 
Nguyen, H., Nutman, T., Zimmerman, P. A., Tucker, M. A., Hud-
son, T., Goldstein, A. M., Lander, E., Lin, A. Y. Familial eosino-
philia maps to the cytokine gene cluster on human chromosomal 
region 5q31-q33. Am. J. Hum. Genet. 1998, 63: 1086-1094. 
[34]  Levitt, R. C., Holroyd, K. J. Fine-structure mapping of genes pro-
viding susceptibility to asthma on chromosome 5q31-q33. Clin. 
Exp. Allergy 1995, 25 Suppl 2: 119-123. 
[35]  Garcia, A., Marquet, S., Bucheton, B., Hillaire, D., Cot, M., Fievet, 
N., Dessein, A. J., Abel, L. Linkage analysis of blood Plasmodium 
falciparum levels: interest of the 5q31-q33 chromosome region. 
Am. J. Trop. Med. Hyg. 1998, 58: 705-709. 
[36]  Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., 
McLeod, R. S., Griffiths, A. M., Green, T., Brettin, T. S., Stone, V., 
Bull, S. B., Bitton, A., Williams, C. N., Greenberg, G. R., Cohen, 
Z., Lander, E. S., Hudson, T. J., Siminovitch, K. A. Genomewide 
search in Canadian families with inflammatory bowel disease re-
veals two novel susceptibility loci. Am. J. Hum. Genet. 2000, 66: 
1863-1870. 
[37]  Marquet, S., Abel, L., Hillaire, D., Dessein, A. Full results of the 
genome-wide scan which localises a locus controlling the intensity 
of infection by Schistosoma mansoni on chromosome 5q31-q33. 
Eur. J. Hum. Genet. 1999, 7: 88-97. 
[38]  Morton, S. M., Bocaccio, I., Depetris, D., Mattei, M., Dessein, A. 
Assignment of IL12RB2 to human chromosome 1p31.3-->p31.2 
between D1S230 and D1S198. Cytogenet. Cell Genet. 1997, 79: 
282-283. 
[39]  Lutfalla, G., Gardiner, K., Proudhon, D., Vielh, E., Uze, G. The 
structure of the human interferon alpha/beta receptor gene. J. Biol. 
Chem. 1992, 267: 2802-2809. 
[40]  Isobe, M., Erikson, J., Emanuel, B. S., Nowell, P. C., Croce, C. M. 
Location of gene for beta subunit of human T-cell receptor at band 
7q35, a region prone to rearrangements in T cells. Science 1985, 
228: 580-582. 
[41]  Dessein, A. J., Hillaire, D., Elwali, N. E., Marquet, S., Mohamed-
Ali, Q., Mirghani, A., Henri, S., Abdelhameed, A. A., Saeed, O. K., 
Magzoub, M. M., Abel, L. Severe hepatic fibrosis in Schistosoma 
mansoni infection is controlled by a major locus that is closely 
linked to the interferon-gamma receptor gene. Am. J. Hum. Genet. 
1999, 65: 709-721. 
[42]  Pearce, E. J., Caspar, P., Grzych, J. M., Lewis, F. A., Sher, A. 
Downregulation of Th1 cytokine production accompanies induction 
of Th2 responses by a parasitic helminth, Schistosoma mansoni. J. 
Exp. Med. 1991, 173: 159-166. 
[43]  Rihet, P., Demeure, C. E., Bourgois, A., Prata, A., Dessein, A. J. 
Evidence for an association between human resistance to Schisto-
soma mansoni and high anti-larval IgE levels. Eur. J. Immunol. 
1991, 21: 2679-2686. 
[44]  Truong, M. J., Gruart, V., Liu, F. T., Prin, L., Capron, A., Capron, 
M. IgE-binding molecules (Mac-2/epsilon BP) expressed by human 
eosinophils. Implication in IgE-dependent eosinophil cytotoxicity. 
Eur. J. Immunol. 1993, 23: 3230-3235. 
[45]  Gounni, A. S., Lamkhioued, B., Ochiai, K., Tanaka, Y., Delaporte, 
E., Capron, A., Kinet, J. P., Capron, M. High-affinity IgE receptor 
on eosinophils is involved in defence against parasites. Nature 
1994, 367: 183-186. 
[46]  Capron, M., Truong, M. J., Aldebert, D., Gruart, V., Suemura, M., 
Delespesse, G., Tourvieille, B., Capron, A. Heterogeneous expres-
sion of CD23 epitopes by eosinophils from patients. Relationships 
with IgE-mediated functions. Eur. J. Immunol.  1991,  21: 2423-
2429. 
[47]  Nyindo, M., Kariuki, T. M., Mola, P. W., Farah, I. O., Elson, L., 
Blanton, R. E., King, C. L.Role of adult worm antigen-specific 
immunoglobulin E in acquired immunity to Schistosoma mansoni 
infection in baboons. Infect. Immun. 1999, 67: 636-642. 
[48]  Cetre, C., Pierrot, C., Cocude, C., Lafitte, S., Capron, A., Capron, 
M., Khalife, J. Profiles of Th1 and Th2 cytokines after primary and 
secondary infection by Schistosoma mansoni in the semipermissive 
rat host. Infect. Immun. 1999, 67: 2713-2719. 
[49]  Cetre, C., Cocude, C., Pierrot, C., Godin, C., Capron, A., Capron, 
M., Khalife, J. In vivo expression of cytokine mRNA in rats in-
fected with Schistosoma mansoni.  Parasite Immunol.  1998,  20: 
135-142. 
[50]  Capron, M., Capron, A., Torpier, G., Bazin, H., Bout, D., Joseph, 
M. Eosinophil-dependent cytotoxicity in rat schistosomiasis. In-
volvement of IgG2a antibody and role of mast cells. Eur. J. Immu-
nol. 1978, 8: 127-133. 
[51]  Capron, M., Nogueira-Queiroz, J. A., Papin, J. P., Capron, A. In-
teractions between eosinophils and antibodies: in vivo protective 
role against rat schistosomiasis. Cell Immunol. 1984, 83: 60-72. 
[52]  Grzych, J. M., Capron, M., Bazin, H., Capron, A. In vitro and in 
vivo effector function of rat IgG2a monoclonal anti-S. mansoni an-
tibodies. J. Immunol. 1982, 129: 2739-2743. 
[53]  Khalife, J., Capron, M., Grzych, J. M., Bazin, H., Capron, A. Fc 
gamma receptors on rat eosinophils: isotype-dependent cell activa-
tion. J. Immunol. 1985, 135: 2780-2784. 
[54]  Grzych, J. M., Capron, M., Dissous, C., Capron, A. Blocking activ-
ity of rat monoclonal antibodies in experimental schistosomiasis. J. 
Immunol. 1984, 133: 998-1004. 
[55]  Dombrowicz, D., Quatannens, B., Papin, J. P., Capron, A., Capron, 
M.Expression of a functional Fc epsilon RI on rat eosinophils and 
macrophages. J. Immunol. 2000, 165: 1266-1271. 300    Current Genomics, 2008, Vol. 9, No. 5  Isnard and Chevillard 
[56]  Khalife, J., Capron, M., Capron, A., Grzych, J. M., Butterworth, A. 
E., Dunne, D. W., Ouma, J. H. Immunity in human schistosomiasis 
mansoni. Regulation of protective immune mechanisms by IgM 
blocking antibodies. J. Exp. Med. 1986, 164: 1626-1640. 
[57]  Hagan, P., Blumenthal, U. J., Dunn, D., Simpson, A. J., Wilkins, H. 
A. Human IgE, IgG4 and resistance to reinfection with Schisto-
soma haematobium. Nature 1991, 349: 243-245. 
[58]  Demeure, C. E., Rihet, P., Abel, L., Ouattara, M., Bourgois, A., 
Dessein, A. J. Resistance to Schistosoma mansoni in humans: in-
fluence of the IgE/IgG4 balance and IgG2 in immunity to reinfec-
tion after chemotherapy. J. Infect. Dis. 1993, 168: 1000-1008. 
[59]  Couissinier-Paris, P., Dessein, A. J. Schistosoma-specific helper T 
cell clones from subjects resistant to infection by Schistosoma 
mansoni are Th0/2. Eur. J. Immunol. 1995, 25: 2295-2302. 
[60]  Rodrigues, V., Jr., Piper, K., Couissinier-Paris, P., Bacelar, O., 
Dessein, H., Dessein, A. J. Genetic control of schistosome infec-
tions by the SM1 locus of the 5q31-q33 region is linked to differen-
tiation of type 2 helper T lymphocytes. Infect. Immun. 1999, 67: 
4689-4692. 
[61]  Kouriba, B., Chevillard, C., Bream, J. H., Argiro, L., Dessein, H., 
Arnaud, V., Sangare, L., Dabo, A., Beavogui, A. H., Arama, C., 
Traore, H. A., Doumbo, O., Dessein, A. Analysis of the 5q31-q33 
locus shows an association between IL13-1055C/T IL-13-591A/G 
polymorphisms and Schistosoma haematobium infections. J. Im-
munol. 2005, 174: 6274-6281. 
[62]  Graves, P. E., Kabesch, M., Halonen, M., Holberg, C. J., Baldini, 
M., Fritzsch, C., Weiland, S. K., Erickson, R. P., von Mutius, E., 
Martinez, F. D.A cluster of seven tightly linked polymorphisms in 
the IL-13 gene is associated with total serum IgE levels in three 
populations of white children. J. Allergy Clin. Immunol. 2000, 105: 
506-513. 
[63]  van der Pouw Kraan, T. C., van Veen, A., Boeije, L. C., van Tuyl, 
S. A., de Groot, E. R., Stapel, S. O., Bakker, A., Verweij, C. L., 
Aarden, L. A., van der Zee, J. S.An IL-13 promoter polymorphism 
associated with increased risk of allergic asthma. Genes Immun. 
1999, 1: 61-65. 
[64]  Cameron, L., Webster, R. B., Strempel, J. M., Kiesler, P., Kabesch, 
M., Ramachandran, H., Yu, L., Stern, D. A., Graves, P. E., 
Lohman, I. C., Wright, A. L., Halonen, M., Klimecki, W. T., Ver-
celli, D. Th2 cell-selective enhancement of human IL13 transcrip-
tion by IL13-1112C>T, a polymorphism associated with allergic 
inflammation. J. Immunol. 2006, 177: 8633-8642. 
[65]  Peisong, G., Yamasaki, A., Mao, X. Q., Enomoto, T., Feng, Z., 
Gloria-Bottini, F., Bottini, E., Shirakawa, T., Sun, D., and Hopkin, 
J. M.An asthma-associated genetic variant of STAT6 predicts low 
burden of ascaris worm infestation. Genes Immun. 2004, 5: 58-62. 
[66]  He, H., Isnard, A., Kouriba, B., Cabantous, S., Dessein, A., 
Doumbo, O., Chevillard, C.A STAT6 gene polymorphism is asso-
ciated with high infection levels in urinary schistosomiasis. Genes 
Immun. 2008, in press. 
[67]  Lynch, N. R., Hagel, I. A., Palenque, M. E., Di Prisco, M. C., Es-
cudero, J. E., Corao, L. A., Sandia, J. A., Ferreira, L. J., Botto, C., 
Perez, M., Le Souef, P. N. Relationship between helminthic infec-
tion and IgE response in atopic and nonatopic children in a tropical 
environment. J. Allergy Clin. Immunol. 1998, 101: 217-221. 
[68]  Araujo, M. I., Lopes, A. A., Medeiros, M., Cruz, A. A., Sousa-Atta, 
L., Sole, D., Carvalho, E. M. Inverse association between skin re-
sponse to aeroallergens and Schistosoma mansoni infection. Int. 
Arch. Allergy Immunol. 2000, 123: 145-148. 
[69]  van den Biggelaar, A. H., van Ree, R., Rodrigues, L. C., Lell, B., 
Deelder, A. M., Kremsner, P. G., Yazdanbakhsh, M. Decreased 
atopy in children infected with Schistosoma haematobium: a role 
for parasite-induced interleukin-10. Lancet 2000, 356: 1723-1727. 
[70]  Medeiros, M., Jr., Figueiredo, J. P., Almeida, M. C., Matos, M. A., 
Araujo, M. I., Cruz, A. A., Atta, A. M., Rego, M. A., de Jesus, A. 
R., Taketomi, E. A., Carvalho, E. M. Schistosoma mansoni infec-
tion is associated with a reduced course of asthma. J. Allergy Clin. 
Immunol. 2003, 111: 947-951. 
[71]  Scrivener, S., Yemaneberhan, H., Zebenigus, M., Tilahun, D., 
Girma, S., Ali, S., McElroy, P., Custovic, A., Woodcock, A., Prit-
chard, D., Venn, A., Britton, J. Independent effects of intestinal 
parasite infection and domestic allergen exposure on risk of wheeze 
in Ethiopia: a nested case-control study. Lancet 2001, 358: 1493-
1499. 
[72]  Nyan, O. A., Walraven, G. E., Banya, W. A., Milligan, P., Van Der 
Sande, M., Ceesay, S. M., Del Prete, G., McAdam, K. P. Atopy, in-
testinal helminth infection and total serum IgE in rural and urban 
adult Gambian communities. Clin. Exp. Allergy  2001, 31: 1672-
1678. 
[73]  Huang, S. L., Tsai, P. F., Yeh, Y. F. Negative association of En-
terobius infestation with asthma and rhinitis in primary school chil-
dren in Taipei. Clin. Exp. Allergy 2002, 32: 1029-1032. 
[74]  Cooper, P. J., Chico, M. E., Rodrigues, L. C., Ordonez, M., 
Strachan, D., Griffin, G. E., Nutman, T. B.Reduced risk of atopy 
among school-age children infected with geohelminth parasites in a 
rural area of the tropics. J. Allergy Clin. Immunol. 2003, 111: 995-
1000. 
[75]  Takeuchi, H., Zaman, K., Takahashi, J., Yunus, M., Chowdhury, H. 
R., Arifeen, S. E., Baqui, A., Wakai, S., Iwata, T. High titre of anti-
Ascaris immunoglobulin E associated with bronchial asthma symp-
toms in 5-year-old rural Bangladeshi children. Clin. Exp. Allergy 
2008, 38: 276-282. 
[76]  Hunninghake, G. M., Soto-Quiros, M. E., Avila, L., Ly, N. P., 
Liang, C., Sylvia, J. S., Klanderman, B. J., Silverman, E. K., Cele-
don, J. C. Sensitization to Ascaris lumbricoides and severity of 
childhood asthma in Costa Rica. J. Allergy Clin. Immunol. 2007, 
119: 654-661. 
[77]  Cooper, P. J., Chico, M. E., Vaca, M. G., Moncayo, A. L., Bland, J. 
M., Mafla, E., Sanchez, F., Rodrigues, L. C., Strachan, D. P., Grif-
fin, G. E. Effect of albendazole treatments on the prevalence of 
atopy in children living in communities endemic for geohelminth 
parasites: a cluster-randomised trial. Lancet 2006, 367: 1598-1603. 
 
 
 
 